Literature DB >> 1064215

Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma.

J S Hillman, J B Marsters, A Broad.   

Abstract

Patients with acute closed-angle glaucoma were treated with a hydrophilic contact lens saturated in 1, 4, or 8 per cent. pilocarpine or bt intensive 4 per cent. pilocarpine drops. The greatest hypotensive response was produced by the 1 per cent. presoaked lens and increased strength of soaking solution gave reduced response. Intensive drops gave the least response. In vitro studies show that the lens is effectively saturated after 2 hrs' soaking holds c. 700 mug. pilocarpine and yields almost all of the contained pilocarpine after 2 hrs' elution. The method of lens preparation is described and pharmaceutical studies confirm a shelf life of 4 months in a domestic refrigerator.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1064215

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  5 in total

1.  Management of acute closed-angle glaucoma with miotics and timolol.

Authors:  P J Airaksinen; K M Saari; T J Tiainen; E A Jaanio
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

2.  Acute closed-angle glaucoma: an investigation into the effect of delay in treatment.

Authors:  J S Hillman
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

3.  In vivo drug delivery via contact lenses: The current state of the field from origins to present.

Authors:  Liana D Wuchte; Stephen A DiPasquale; Mark E Byrne
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-18       Impact factor: 5.062

4.  Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.

Authors:  Saman Mohammadi; Lyndon Jones; Maud Gorbet
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

5.  Controlled Release of Multiple Therapeutics From Silicone Hydrogel Contact Lenses for Post-Cataract/Post-Refractive Surgery and Uveitis Treatment.

Authors:  Stephen A DiPasquale; Biaggio Uricoli; Matthew C DiCerbo; Thea L Brown; Mark E Byrne
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.